IT Matters: The Erectile Restoration Registry

← catalyst calendar

NCT04200937 · readout ≤ 1,625 d

Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.

Phase

—

Status

Enrolling by invitation

Study type

Observational

Enrollment

450estimated

Sites

Countries

China, Saudi Arabia, United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2021-08-05

actual

When the study began enrolling

Primary completion

Jan 2031

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

Dec 2031

estimated

The whole study's end, after follow-up

First posted

2019-12-16

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-08-12

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

Erectile Dysfunction

Interventions

Device: Tactra Malleable
Device: Spectra™ Concealable Penile Prothesis
Device: AMS Ambicor™ Inflatable Penile Prosthesis
Device: AMS 700™ Inflatable Penile Prosthesis w/Momentary Squeeze (MS) Pump
Device: AMS 700™ Inflatable Penile Prosthesis w/Tenacio™ Pump

Primary outcome

what the primary-completion date above is the date OF

Change from baseline to six months in the Erectile Function domain ofthe International Index of Erectile Function (IIEF-EF) questionnaire for Tactra

measured Baseline to 6 months

Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed